"AMP Deaminase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An enzyme that catalyzes the deamination of AMP to IMP. EC 3.5.4.6.
Concept/Terms
AMP Deaminase- AMP Deaminase
- Deaminase, AMP
- Adenylate Deaminase
- Deaminase, Adenylate
- Myoadenylate Deaminase
- Deaminase, Myoadenylate
- AMP Aminohydrolase
- Aminohydrolase, AMP
- 5'-AMP Deaminase
- 5' AMP Deaminase
- Deaminase, 5'-AMP
- AMP Aminase
- Aminase, AMP
Below are MeSH descriptors whose meaning is more general than "AMP Deaminase".
Below are MeSH descriptors whose meaning is more specific than "AMP Deaminase".
This graph shows the total number of publications written about "AMP Deaminase" by people in Harvard Catalyst Profiles by year, and whether "AMP Deaminase" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 1 | 0 | 1 |
2000 | 1 | 1 | 2 |
2014 | 1 | 0 | 1 |
2022 | 1 | 0 | 1 |
Below are the most recent publications written about "AMP Deaminase" by people in Profiles.
-
Delineating the phenotype and genetic basis of AMPD2-related pontocerebellar hypoplasia. Neurogenetics. 2023 01; 24(1):61-66.
-
Association between the C34T polymorphism of the AMPD1 gene and essential hypertension in Malaysian patients. Genet Mol Res. 2016 Jun 20; 15(2).
-
A mutation in Ampd2 is associated with nephrotic syndrome and hypercholesterolemia in mice. Lipids Health Dis. 2014 Oct 31; 13:167.
-
The impact of AMPD1 gene polymorphism on vascular function and inflammation in patients with coronary artery disease. Int J Cardiol. 2014 Apr 01; 172(3):e516-8.
-
Metformin activates AMP kinase through inhibition of AMP deaminase. J Biol Chem. 2011 Jan 07; 286(1):1-11.
-
Metalloproteinase inhibitor counters high-energy phosphate depletion and AMP deaminase activity enhancing ventricular diastolic compliance in subacute heart failure. J Pharmacol Exp Ther. 2006 May; 317(2):506-13.
-
Differences in activities of the enzymes of nucleotide metabolism and its implications for cardiac xenotransplantation. Nucleosides Nucleotides Nucleic Acids. 2006; 25(9-11):1221-4.
-
Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol Genet Metab. 2000 Sep-Oct; 71(1-2):10-8.
-
IMP and AMP deaminase in reperfusion injury down-regulates neutrophil recruitment. Proc Natl Acad Sci U S A. 2000 Apr 11; 97(8):4267-72.
-
Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. Circulation. 1999 Mar 23; 99(11):1422-5.